Johnson & Johnson (JNJ) 13D/13G Filings for Contineum Therapeutics, Inc. Class A Common Stock (CTNM)

Johnson & Johnson 13D and 13G filings for Contineum Therapeutics, Inc. Class A Common Stock:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-04-10
5:12 pm
Purchase
2024-04-09 13G Contineum Therapeutics, Inc. Class A Common Stock
CTNM
JOHNSON & JOHNSON
JNJ
1,979,173
10.700%
1,979,173increase
(New Position)
Filing